Nina Capital is a venture capital firm that focuses on investing in early-stage healthcare startups. The firm aims to support companies that are leveraging technology to create innovative solutions in the healthcare sector, with a particular interest in biotech, digital health, and medical devices. Nina Capital seeks to contribute to the improvement of health outcomes by backing visionary entrepreneurs and disruptive technologies.

Nina Capital

We have a vision for the future in which data, computing, networks, and other digital and deep technologies deliver meaningful outcomes and insight for improving health and the provision of care. We believe the creation of new businesses is built on in-depth understanding of the complex network of healthcare system participants, and marrying that with meaningful engineering innovation, advanced data science, and information technology-enabled products and services. We look for and seed founders determined to effectively and efficiently serve these participants on the european continent and internationally. We are committed to addressing needs across the care continuum, healthcare systems, and all specialties. 

Replica Analytics

did you know?
our venture partners have collective decades of experience in leadership in some of the world's top medtech manufacturers, companies and institutions like Microsoft, Philips, Apple, NHS, Hewlett Packard Enterprise, Optum, Aetna, a CVS Health Company, Eagle Genomics or Bupa.

We are very proud to be collaborating with top venture partners based around the world. These outstanding professionals increase the capacities of our core team with their wide-ranging experience and networks.

Meet our venture partners:
💫  Rebecca Schechter 
💫 Helen Routh
💫 Anil Sethi
💫 Abel Ureta-Vidal
💫 Dr Hemal Desai

More info on our website: https://lnkd.in/d4knYqhQ 

#venturepartner #venturecapital #investment #healthtech #innovation #wearenina

Artificial intelligence and breast cancer: What's next?

https://lnkd.in/dDrEMrHA

Kheiron Medical #oncology #breastcancer #cancer #innovation #screening #wearenina

"No"
"No!"
"Sorry, no."
"I like you, but no."
"Not yet."
"No, thank you."
"Nope. Good luck!"
...

In the startup world, when you are fundraising, the "NO" responses come much more numerous than the "YES" responses, and to make matters worse, they come earlier. That's if you are lucky and no one is subjecting you to radio silence (a period when someone does not communicate despite having established a solid and promising communication channel).

Almost everyone is a champion at handling a "YES." We are all the worst versions of ourselves when we are rejected. When you open your inbox and see a "NO," don't hurry into making a mistake. 

Check your heart rate. Is it accelerating? Are the memories of all the hard work you put in to get this far causing distress? Do you feel heavy on your chest the task of breaking the disappointing news with your cofounders, employees, or Board of Directors?

If any of that is true, stop. Snooze the email until later. Wait to respond for one, three, or more days. Put a reminder on the calendar to respond in a week. When you're ready to respond using your heart and your brain, and not your stomach, go back to that "NO." If you see a learning opportunity, go after it politely. If not, say thanks (and mean it) and move on. 

What you are doing is special, and it is not obvious. Many people will make a mistake by turning you down. In fact, most will. That's okay. You don't need many people—just the few right ones.

Be kind and smart, always. If you can't be smart, at least be kind. The people you're speaking with may be genuinely your biggest fan club at the same time as they are saying "NO." And even if not, there are still people, even if they just made a mistake.

And remember, it's not supposed to be easy. Otherwise, it would not be special, and it would be quite obvious. Now, time to get ready for the next pitch.

#fundraising #wearenina Nina Capital 

NEWS

QuantHealth is one of Fast Company’s Most Innovative Companies in Europe, the Middle East, and Africa for 2024.

'This startup uses AI to simulate clinical trials and speed new drugs to market'

Read the feature in Fast Company:
https://lnkd.in/ekTMs_hj

Congrats Orr Inbar and team for this amazing recognition 

#healthtech #innovation #clinicaltrials #drugdiscovery #wearenina

Healee revolutionizes healthcare with AI for better patient experience

'The stark contrast between the user experience in sectors like banking, shopping, and travel compared to healthcare is strikingly evident. Healthcare often lags behind, offering a more cumbersome and less user-friendly experience. Addressing this gap, Healee, co-founded by Plamen Petrov, Ph.D., Hristo Kosev, and Josif Dishliev, is set on revolutionizing the healthcare landscape by integrating consumer-friendly experiences through AI technology that people have become accustomed to in other areas of their lives'.

Read more: 
https://lnkd.in/eZyjvfcj

#innovation #healthtech #patientexperience #AI #wearenina

CAPITAL:NINA

Nina Capital

name

homepage url

country

linkedin url

crunchbase url

employee count

sector

industry

monthly webtraffic

monthly webtraffic growth

Description

peer of

invested in

Metrics